High Mortality Associated with Intracardiac and Intrapulmonary Thromboses after Cardiopulmonary Bypass
In this retrospective review, we attempt to identify risk factors and propose possible mechanisms of thromboses after cardiopulmonary bypass (CPB).
Influence of Hemodynamic Variations on the Pharmacokinetics of Landiolol in Patients Undergoing Cardiovascular Surgery
We investigated the influence of hemodynamic variation and the following hepatocirculatory changes after systemic heparinization on the pharmacokinetics of landiolol in patients undergoing cardiovascular surgery under cardiopulmonary bypass.
Preoperative Anaemia is Common in Patients undergoing Major Gynaecological Surgery and is Associated with a Fivefold Increased Risk of Transfusion
This study demonstrates preoperative anaemia is common in women undergoing elective major gynaecological surgery and is associated with increased red cell transfusions.
Evaluation and Comparison of Using Low-Dose Aprotinin and Tranexamic Acid in CABG: A Double Blind Randomized Clinical Trial
Low-dose aprotinin and tranexamic acid can significantly reduce blood loss and transfusion requirement in CABG without importantly increasing mortality and morbidity.
Is a Cell Saver Necessary in Off-Pump Coronary Artery Bypass Surgery?
The use of a cell saver in off-pump surgery is useless in most cases.
Tolerability of Different Oral Iron Supplements: A Systematic Review
Extended-release ferrous sulphate with mucoproteose appears to be the best tolerated of the different oral iron supplements evaluated.
A Retrospective Analysis of Blood Loss with Combined Topical and Intravenous Tranexamic Acid after Coronary Artery Bypass Graft Surgery
The current study explores the use of combined topical and intravenous tranexamic acid as a blood conservation strategy in cardiac surgery.
Perioperative Coagulation Management During Cardiac Surgery
Prospective randomized multicenter studies are needed to confirm the hypothesis that algorithm-based specific hemotherapy in conjunction with POC testing minimizes patient's exposure to blood products and improves clinical outcome.
Effects of Fibrinogen Concentrate as First-line Therapy during Major Aortic Replacement Surgery: A Randomized, Placebo-controlled Trial
Hemostatic therapy with fibrinogen concentrate in patients undergoing aortic surgery significantly reduced the transfusion of allogeneic blood products. Larger multicenter studies are necessary to confirm the role of fibrinogen concentrate in the management of perioperative bleeding in patients with life-threatening coagulopathy.
Transfusion and Risk of Acute Kidney Injury in Cardiac Surgery
This narrative review focuses on the relationship between perioperative red blood cell transfusion and AKI after cardiac surgery with cardiopulmonary bypass (CPB).
Overview of TEG and Its Use in Cardiac Surgery (Video)
The TEG® 5000 Hemostasis Analyzer System provides a more complete picture of patients hemostasis, thus helping you deliver more targeted treatment. Adding TEG to your hemostasis management can help improve patient outcomes and may decrease healthcare costs.
Data and Patient Blood Management (Video)
A successful Blood Management Program can help improve hospital performance and deliver value. IMPACT® Online is at the core of our approach to a strong patient blood management program providing insight and analysis into your blood utilization program.